A new set of variants that scientists are calling "FLiRT" is rising. NPR's Ailsa Chang speaks with Dr. Ashish Jha, Dean of the Brown University School of Public Health about what it means for summer.
After a 2022 law lifted the ban on Medicare negotiating drug prices, the government is in talks to lower prices on 10 medicines that cost the program billions of dollars a year. How's it going?
NPR's A Martínez visits Georgia to see the problems some Americans have accessing healthcare and to hear from providers about what they need to fix it.
There's excitement and controversy swirling around the potential use of MDMA for treating post-traumatic stress disorder. On Tuesday, a panel of advisers to the FDA will evaluate the data.
An innovative program in Tampa aims to stop community violence by focusing on teens arrested for carrying guns. It offers support and mentors so they can get a new start outside of the jail system.
13 states introduced bills this year that could give rights to embryos and fetuses associated with people. None passed yet but IVF patients and doctors fear such laws could limit fertility treatment.
The FDA will review data to decide whether to approve MDMA, also known as ecstasy, for PTSD treatment. Biden is expected to issue an executive order addressing asylum seekers at the southern border.